Xtant Medical Holdings Inc. buy krebskrebs
Start price
09.09.20
/
50%
€0.63
Target price
04.11.21
€1.20
Performance (%)
61.60%
End price
05.11.21
€1.01
Summary
This prediction ended on 05.11.21 with a price of €1.01. With a performance of 61.60% the BUY prediction by krebskrebs was a big success. krebskrebs has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Xtant Medical Holdings Inc. | - | - | - | - |
iShares Core DAX® | -1.471% | 1.895% | 25.178% | 22.236% |
iShares Nasdaq 100 | -0.486% | 4.395% | 29.415% | 42.175% |
iShares Nikkei 225® | -2.115% | 2.450% | 20.561% | 6.454% |
iShares S&P 500 | 0.394% | 3.118% | 29.456% | 42.672% |
Comments by krebskrebs for this prediction
In the thread Xtant Medical Holdings Inc. diskutieren
Buy mit Kursziel 1,2
In the thread Trading Xtant Medical Holdings Inc.
Die von krebskrebs gewählte maximale Laufzeit wurde überschritten